KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elevance Health (ELV) Net Income towards Common Stockholders (2016 - 2026)

Elevance Health has reported Net Income towards Common Stockholders over the past 17 years, most recently at $1.8 billion for Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 19.41% to $1.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.2 billion through Mar 2026, down 11.33% year-over-year, with the annual reading at $5.7 billion for FY2025, 5.19% down from the prior year.
  • Net Income towards Common Stockholders was $1.8 billion for Q1 2026 at Elevance Health, up from $546.0 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $2.3 billion in Q2 2024 and troughed at $413.0 million in Q4 2024.
  • The 5-year median for Net Income towards Common Stockholders is $1.6 billion (2022), against an average of $1.5 billion.
  • Biggest five-year swings in Net Income towards Common Stockholders: tumbled 50.3% in 2024 and later skyrocketed 32.2% in 2025.
  • Tracing ELV's Net Income towards Common Stockholders over 5 years: stood at $877.0 million in 2022, then fell by 5.25% to $831.0 million in 2023, then tumbled by 50.3% to $413.0 million in 2024, then skyrocketed by 32.2% to $546.0 million in 2025, then skyrocketed by 222.34% to $1.8 billion in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at $1.8 billion, $546.0 million, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.